Services
Trend analysis for innovation, FDA and regulatory insights, innovation opportunity assessment, and M&A, divestiture, and transaction support.
The Work
Companies and investors often need to act before all the answers are available — understanding whether an opportunity is real, whether an ingredient or benefit space is becoming credible, whether claims are ownable, whether FDA precedent creates risk, or whether a transaction carries hidden regulatory or quality exposure.
Insight to help leaders decide where to play, what to build, what to claim, and what evidence is needed — integrating competitive activity, ingredient science, benefit trends, regulatory precedent, and claims feasibility.
Services
Detailed information on each service is available on request. Get in touch →
Analysis of FDA Complete Response Letters to surface recurring deficiencies, review-division expectations, approval barriers, and resubmission risk.
Learn More →Assessment of emerging benefit areas, ingredients, consumer territories, scientific support, claims potential, regulatory feasibility, and timing.
Learn More →Category and innovation prioritization across supplements, women's health, longevity, gut health, skin health, postbiotics, and adjacent spaces.
Learn More →Regulatory due diligence, claims and quality risk assessment, management presentation support, diligence Q&A preparation, and post-transaction integration or remediation planning.
Learn More →How We Engage
RGM engagements are designed around the decision the client needs to make — from focused, time-bound assessments to ongoing strategic advisory support.
CRL Compass precedent scan on a target indication
Competitive opportunity assessment
Regulatory due diligence
Investor diligence Q&A preparation
Quarterly category/trend insights subscription
Multi-deal diligence support
Post-transaction regulatory integration
IPO regulatory-readiness program
More Services
